Simultaneous analysis of highly polar pharmaceutical adulterants in slimming products by hydrophilic interaction liquid chromatography

References

• Kim, J. W.; Kweon, S. J.; Park, S. K.; Kim, J. Y.; Lee, J. H.; Han, K. M.; Cho, S.; Kim, J.; Han, S. Y.; Kim, H. J.; Kim, W. S. Isolation and Identification of a Sibutramine Analogue Adulterated in Slimming Dietary Supplements. Food Addit. Contam. Part A Chem. Anal. Control. Expo. Risk Assess. 2013, 30, 1221–1229.
   PubMed Web of Science ®Google Scholar
• Jung, J.; Hermanns-Clausen, M.; Weinmann, W. Anorectic Sibutramine Detected in a Chinese Herbal Drug for Weight Loss. Forensic Sci. Int. 2006, 161, 221–222.
   PubMed Web of Science ®Google Scholar
• Tainted Weight Loss Products. In US Food and Drug Administration [Online]. http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/MedicationHealthFraud/ucm234592.html (accessed May 9, 2016).
   Google Scholar
• Dangerous and Unauthorized Weight Loss Products Continue to Be Sold Across Canada. In Health Canada [Online], July 24, 2013. http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/15042a-eng.php (accessed May 9, 2016).
   Google Scholar
• Slimming products warning issued. In Hong Kong’s Department of Health [Online], http://www.news.gov.hk/en/categories/health/html/2013/06/20130607_174810.shtml (accessed May 9, 2016).
   Google Scholar
• Sivarajah, V.; Abdul, Q.; Pardoe, H.; Lunniss, P. Ulcerative Colitis Associated with the Herbal Weight Loss Supplement Hydroxycut. In BMJ Case Rep.[Online], January 3, 2013. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603930/ (accessed May 9, 2016).
   Google Scholar
• Alert issued on slimming product. In Hong Kong’s Department of Health [Online]. http://www.news.gov.hk/en/categories/health/html/2013/04/20130418_184606.shtml (accessed May 9, 2016).
   Google Scholar
• van Hunsel, F.; van Grootheest, K. Adverse Drug Reactions of a Slimming Product Contaminated with Sibutramine (in Dutch). Ned. Tijdschr. Geneeskd. 2011, 155, A3695.
   PubMedGoogle Scholar
• Akinyemi, E.; Bercovici, S.; Niranjan, S.; Paul, N.; Hemavathy, B. Thyrotoxic Hypokalemic Periodic Paralysis due to Dietary Weight-loss Supplement. Am. J. Ther. 2011, 18, e81–e83.
   Google Scholar
• Palmer, M. E.; Haller, C.; McKinney, P. E.; Klein-Schwartz, W.; Tschirgi, A.; Smolinske, S. C.; Woolf, A.; Sprague, B. M.; Ko, R.; Everson, G.; Nelson, L. S.; Dodd-Butera, T.; Bartlett, W. D.; Landzberg, B. R. Adverse Events Associated with Dietary Supplements: An Observational Study. Lancet 2003, 361, 101–106.
   PubMed Web of Science ®Google Scholar
• Adachi, M.; Saito, H.; Kobayashi, H.; Horie, Y.; Kato, S.; Yoshioka, M.; Ishii, H. Hepatic Injury in 12 Patients Taking the Herbal Weight Loss AIDS Chaso or Onshido. Ann. Intern. Med. 2003, 139, 488–492.
   PubMed Web of Science ®Google Scholar
• Date, H.; Terauchi, M.; Sugimura, M.; Toyota, A.; Matsuo, T. Systematic Analysis of Oral Hypoglycemic Agents in Health Foods. Yakugaku Zasshi 2009, 129, 163–172.
   PubMed Web of Science ®Google Scholar
• Rebiere, H.; Guinot, P.; Civade, C.; Bonnet, P. A.; Nicolas, A. Detection of Hazardous Weight-loss Substances in Adulterated Slimming Formulations using Ultra-high-pressure Liquid Chromatography with Diode-array Detection. Food Addit. Contam. Part A Chem. Anal. Control. Expo. Risk Assess. 2012, 29, 161–171.
   PubMed Web of Science ®Google Scholar
• Kim, S. H.; Lee, J.; Yoon, T.; Yoshioka, J.; Choi, D.; Kim, D.; Kwon, S. W. Simultaneous Determination of Anti-diabetes/Anti-obesity Drugs by LC/PDA, and Targeted Analysis of Sibutramine Analog in Dietary Supplements by LC/MS/MS. Biomed. Chromatogr. 2009, 23, 1259–1265.
   PubMed Web of Science ®Google Scholar
• Dejaegher, B.; Vander Heyden, Y. HILIC Methods in Pharmaceutical Analysis. J. Sep. Sci. 2010, 33, 698–715.
   PubMed Web of Science ®Google Scholar
• Quiming, N. S.; Denola, N. L.; Ueta, I.; Tatematsu, S.; Jinno, K. Retention Prediction of Adrenoreceptor Agonists and Antagonists on a Diol Column in Hydrophilic Interaction Chromatography. Anal. Chim. Acta. 2007, 598, 41–50.
   PubMed Web of Science ®Google Scholar
• Jeong, D. W.; Kim, Y. H.; Ji, H. Y.; Youn, Y. S.; Lee, K. C.; Lee, H. S. Analysis of Carvedilol in Human Plasma using Hydrophilic Interaction Liquid Chromatography with Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2007, 44, 547–552.
   PubMed Web of Science ®Google Scholar
• Quiming, N. S.; Denola, N. L.; Saito, Y.; Jinno, K. Retention Prediction of Adrenoreceptor Agonists and Antagonists on Unmodified Silica Phase in Hydrophilic Interaction Chromatography. Anal. Bioanal. Chem. 2007, 388, 1693–1706.
   PubMed Web of Science ®Google Scholar
• Kawano, S. Analysis of Impurities in Streptomycin and Dihydrostreptomycin by Hydrophilic Interaction Chromatography/Electrospray Ionization Quadrupole Ion Trap/Time-of-flight Mass Spectrometry. Rapid Commun. Mass. Spectrom. 2009, 23, 907–914.
   PubMed Web of Science ®Google Scholar
• Xu, Y.; Xie, W.; Miller-Stein, C. M.; Woolf, E. J. Hydrophilic Interaction Chromatography/Tandem Mass Spectrometry for the Simultaneous Determination of Three Polar Non-structurally Related Compounds, Imipenem, Cilastatin and an Investigational Beta-Lactamase Inhibitor, MK-4698, in Biological Matrices. Rapid Commun. Mass. Spectrom. 2009, 23, 2195–2205.
   PubMed Web of Science ®Google Scholar
• Hsieh, Y. Hydrophilic Interaction Liquid Chromatography-tandem Mass Spectrometry for Drug Development. Curr. Drug Discov. Technol. 2010, 7, 223–231.
   PubMedGoogle Scholar
• Chauve, B.; Guillarme, D.; Cleon, P.; Veuthey, J. L. Evaluation of Various HILIC Materials for the Fast Separation of Polar Compounds. J. Sep. Sci. 2010, 33, 752–764.
   PubMed Web of Science ®Google Scholar
• Kong, N.; Yi, R.; Zhao, S.; Sandhu, J.; Lam, G.; Loganathan, D.; Morrissey, B. Development and Validation of a Hydrophilic Interaction Liquid Chromatography with Tandem Mass Spectrometry Method for the Simultaneous Detection and Quantification of Etilefrine and Oxilofrine in Equine Blood Plasma and Urine. J. Sep. Sci. 2014, 37, 3015–3023.
   PubMed Web of Science ®Google Scholar
• Kernan, W. N.; Viscoli, C. M.; Brass, L. M.; Broderick, J. P.; Brott, T.; Feldmann, E.; Morgenstern, L. B.; Wilterdink, J. L.; Horwitz, R. I. Phenylpropanolamine and the Risk of Hemorrhagic Stroke. N. Engl. J. Med. 2000, 343, 1826–1832.
   PubMed Web of Science ®Google Scholar
• Schiffelers, S. L.; Saris, W. H.; Boomsma, F.; van Baak, M. A. Beta(1)- and beta(2)- Adrenoceptor-mediated Thermogenesis and Lipid Utilization in Obese and Lean Men. J. Clin. Endocrinol. Metab. 2001, 86, 2191–2199.
   PubMed Web of Science ®Google Scholar
• Wilson, D. M.; Abrams, S. H.; Aye, T.; Lee, P. D. K.; Lenders, C.; Lustig, R. H.; Osganian, S. V.; Feldman, H. A.; Glaser Pediatric Research Network Obesity Study Group. Metformin Extended Release Treatment of Adolescent Obesity: A 48-week Randomized, Double-blind, Placebo-controlled Trial with 48-week Follow-up. Arch. Pediatr. Adolesc. Med. 2010, 164, 116–123.
   PubMedGoogle Scholar
• Code Q2(R1)-Validation of Analytical Procedures: Text and Methodology, 2005, ICH Harmonised Tripartite Guideline.
   Google Scholar